[HTML][HTML] Prognostic significance of baseline neutrophil count and lactate dehydrogenase level in patients with esophageal squamous cell cancer treated with …
HS Luo, HY Xu, ZS Du, XY Li, SX Wu, HC Huang… - Frontiers in …, 2020 - frontiersin.org
Background: This present study aimed to explore the prognostic value of pretreatment
neutrophil and lactate dehydrogenase (LDH) and to develop a prognostic risk scoring model …
neutrophil and lactate dehydrogenase (LDH) and to develop a prognostic risk scoring model …
[HTML][HTML] The prognostic role of pre-treatment neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in esophageal squamous cell carcinoma treated with …
Q Man, P Li, J Fan, S Yang, C Xing, Y Bai, M Hu… - BMC cancer, 2024 - Springer
Purpose In this study, we retrospectively investigated the prognostic role of pre-treatment
neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) in esophageal …
neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) in esophageal …
[HTML][HTML] A new risk score model based on lactate dehydrogenase for predicting prognosis in esophageal squamous cell carcinoma treated with chemoradiotherapy
C Liu, J Han, D Han, W Huang, B Li - Journal of Thoracic Disease, 2023 - ncbi.nlm.nih.gov
Background The prognostic role of lactate dehydrogenase (LDH) has been confirmed in
many malignant tumors, but it has not been widely discussed in esophageal squamous cell …
many malignant tumors, but it has not been widely discussed in esophageal squamous cell …
[HTML][HTML] Combined neutrophil-platelet score and hemoglobin level predict survival in esophageal squamous cell carcinoma patients treated with chemoradiotherapy
C Miao, S Zhu, H Pan, X Cao, S Yuan, X Hu - Oncotarget, 2017 - ncbi.nlm.nih.gov
Systemic inflammation and hematological markers have prognostic value in patients with
esophageal squamous cell carcinoma (ESCC). The objective of this study was to evaluate …
esophageal squamous cell carcinoma (ESCC). The objective of this study was to evaluate …
The impact of lymphopenia and dosimetric parameters on overall survival of esophageal cancer patients treated with definitive radiotherapy
M Liu, X Li, H Cheng, Y Wang, Y Tian - Cancer Management and …, 2021 - Taylor & Francis
Purpose The objectives of the present study are to perform a survival analysis of patients
with thoracic esophageal squamous cell carcinoma (ESCC) receiving definitive radiotherapy …
with thoracic esophageal squamous cell carcinoma (ESCC) receiving definitive radiotherapy …
[HTML][HTML] Elevated platelet-to-Lymphocyte ratio and neutrophil-to-Lymphocyte ratio after first cycle of chemotherapy and better survival in esophageal cancer patients …
RH Tseng, KM Lai, CY Tsai, SL Yan - Current Oncology, 2022 - mdpi.com
Background: Prognostic factors for poor survival have been proposed in esophageal
squamous cell carcinoma (SCC) patients receiving concurrent chemoradiotherapy (CCRT) …
squamous cell carcinoma (SCC) patients receiving concurrent chemoradiotherapy (CCRT) …
Hematologic markers as prognostic factors in nonmetastatic esophageal cancer patients under concurrent chemoradiotherapy
Nonmetastatic esophageal cancer can demonstrate a high local recurrence rate even under
the standard treatment. We evaluated platelet counts before and after concurrent …
the standard treatment. We evaluated platelet counts before and after concurrent …
Prognostic values of neutrophil-to-lymphocyte ratio and hemoglobin-to-white blood cell ratio on non-operative esophageal squamous cell carcinoma patients
Q Zhang, W Chen, Z Lin, X Peng, Z HU… - Chinese Journal of …, 2017 - pesquisa.bvsalud.org
Objective To evaluate the predictive value of neutrophil-to-lymphocyte ratio (NLR) and
hemoglobinto-white blood cell ratio (HWR) prior to treatment in prognosis of non-operative …
hemoglobinto-white blood cell ratio (HWR) prior to treatment in prognosis of non-operative …
[HTML][HTML] Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive …
XL Zhou, YQ Li, WG Zhu, CH Yu, YQ Song… - Scientific reports, 2017 - nature.com
The present study evaluated the clinical and prognostic value of neutrophil-to-lymphocyte
ratio (NLR) in patients with locally advanced esophageal squamous cell carcinoma (ESCC) …
ratio (NLR) in patients with locally advanced esophageal squamous cell carcinoma (ESCC) …
Sensitivity value of hematological markers in patients receiving chemoradiotherapy for esophageal squamous cell carcinoma
S Zhu, CW Miao, ZT Wang, L Peng… - OncoTargets and therapy, 2016 - Taylor & Francis
Background Hematological markers of the systemic inflammatory response (SIR) including
the neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and the …
the neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and the …